Mainz Biomed B.V. Gains 36.23%
Wed, Jul 31, 2024 at 07:10 PM
Mainz Biomed B.V. (MYNZ:NASDAQ) shot up at $0.47, representing a gain of 36.2%. On Wed, Jul 31, 2024, MYNZ:NASDAQ touched a New 2-Week High of $0.47. The stock appeared on our News Catalysts scanner on Tue, Jul 30, 2024 at 02:10 PM in the 'BIOTECH' category. From Wed, Jul 17, 2024, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Mon, Jul 08, 2024 at $0.56 with a volume of 3M+.
About Mainz Biomed B.V. (MYNZ:NASDAQ)
Mainz Biomed BV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions.
Top 10 Gainers:
- noco-noco Inc. (NCNC:NASDAQ), 87.58%
- NextPlay Technologies Inc. (NXTP:NASDAQ), 76.92%
- Primech Holdings Ltd. (PMEC:NASDAQ), 57.73%
- Lakeside Holding Limited (LSH:NASDAQ), 55.74%
- DallasNews Corporation (DALN:NASDAQ), 38.72%
- Powell Industries, Inc. (POWL:NASDAQ), 37.81%
- Molecular Partners AG (MOLN:NASDAQ), 36.84%
- Mainz Biomed B.V. (MYNZ:NASDAQ), 36.23%
- IM Cannabis Corp. (IMCC:NASDAQ), 34.93%
- Bright Scholar Education Holdings Limited (BEDU:NYSE), 33.33%